ArticleHaematologica2023

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes.

Charlotte B Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.